Targeted Sector Focus Technology Commercialization Group specializes in serving life science companies across medical devices, diagnostics, pharmaceuticals, biotech, digital health, and health IT, indicating a deep understanding of sophisticated healthcare innovation markets which can be leveraged for tailored solutions.

Geographic Expansion With offices in North America and Europe, and recent expansion into Japan and Eastern Asia, TCG presents unique opportunities to connect global healthcare firms seeking localized market entry and strategic partnership support.

High-Impact Leadership Led by senior partners with over 25 years of industry experience, TCG offers high-value, personalized consulting and interim management services, appealing to clients needing experienced guidance through complex market entry or asset commercialization projects.

Strategic Partnerships Recent collaborations with initiatives like MedTech Innovator demonstrate TCG’s visibility within innovative startup ecosystems, creating potential avenues to connect with emerging medical technology companies seeking commercialization expertise.

Growth Potential Operating with a revenue range of one to ten million dollars and focusing on health technology, TCG has substantial room for expansion within its niche market, making it a compelling target for service providers offering complementary solutions or strategic alliances.